Similar Sites to cuvitruhcp.com
Monthly Visit
143,221
Global Rank
#195,934
Take Action With DUPIXENT® (dupilumab) — Learn more about DUPIXENT® (dupilumab), a prescription medicine FDA-approved...
Monthly Visit
81,326
Global Rank
#329,674
Independent School Network | South Africa | Curro — Curro is the leading independent school network in South Africa t...
Monthly Visit
23,358
Global Rank
#1.0M
We do not have a description about cur8trend.com but it receives 23,358 users monthly, mostly from United States.
Monthly Visit
3,219
Global Rank
#6.3M
LONSURF® (trifluridine and tipiracil) tablets | Approved for use in Combination with bevacizumab as a 3L Treatment fo...
Monthly Visit
59
Global Rank
n/a
INQOVI® (decitabine and cedazuridine) tablets | MDS Treatment — INQOVI is a prescription oral medication indicated fo...
Website Information
| Domain | cuvitruhcp.com |
| Title | CUVITRU® Subcutaneous Immune Globulin (SCIG) Info for HCPs |
| Description | CUVITRU® [Ig Subcutaneous (Human)] 20% Solution is a SCIG therapy with customized administration for your patients. See Important Safety Info & Thrombosis Warning in Full Prescribing Info. |
Network & Domain Data
HTTP 200| URL | https://cuvitruhcp.com |
| HTTP | HTTP/2 301 |
| strict-transport-security | max-age=63072000; includeSubdomains; |
| cache-control | max-age=31536000,stale-while-revalidate=43200,stale-if-error=43200,max-age=300 |
| location | https://www.cuvitruhcp.com/ |
| expires | Mon, 27 Jul 2026 13:33:54 GMT |
| content-type | text/html; charset=iso-8859-1 |
| accept-ranges | bytes |
| date | Thu, 30 Jul 2026 16:13:29 GMT |
| age | 269075 |
| x-served-by | cache-fra-eddf8230071-FRA |
| x-cache | HIT |
| x-timer | S1785428010.678470,VS0,VS0,VE1 |
| content-length | 275 |
| HTTP/2 200 | |
| strict-transport-security | max-age=63072000; includeSubdomains; |
| x-frame-options | SAMEORIGIN |
| last-modified | Thu, 30 Jul 2026 06:17:33 GMT |
| etag | "12757-657ce0713fe1f" |
| cache-control | max-age=300,stale-while-revalidate=3600 |
| expires | Thu, 30 Jul 2026 16:18:30 GMT |
| x-vhost | cuvitruhcp |
| x-xss-protection | 1; mode=block |
| content-type | text/html;charset=utf-8 |
| x-content-type-options | nosniff |
| accept-ranges | bytes |
| age | 0 |
| date | Thu, 30 Jul 2026 16:13:30 GMT |
| set-cookie | affinity="798131238f7f62c7"; Path=/; HttpOnly; secure |
| x-served-by | cache-fra-eddf8230136-FRA |
| x-cache | MISS |
| x-timer | S1785428010.715561,VS0,VS0,VE598 |
| vary | Accept-Encoding |
| content-length | 75607 |
A
151.101.67.10
TTL 892
A
151.101.195.10
TTL 892
A
151.101.3.10
TTL 892
A
151.101.131.10
TTL 892
NS
ns-396.awsdns-49.com
TTL 21600
NS
ns-1041.awsdns-02.org
TTL 21600
NS
ns-1583.awsdns-05.co.uk
TTL 21600
NS
ns-701.awsdns-23.net
TTL 21600
TXT
v=spf1 -all
TTL 900
| Subject (CN) | cuvitruhcp.com |
| Issuer | YR1 |
| Valid From | 2026-06-28 13:27:11 |
| Valid To | 2026-09-26 13:27:10 |
| Serial Number | 05db1977ee706039aa7ff7ba74057bc47f5d |
| Domain Name | CUVITRUHCP.COM |
| Registry Domain ID | 2673464785_DOMAIN_COM-VRSN |
| Registrar WHOIS Server | whois.corporatedomains.com |
| Registrar URL | http://cscdbs.com |
| Updated Date | 2026-02-03T06:05:32Z |
| Creation Date | 2022-02-07T10:43:10Z |
| Registry Expiry Date | 2027-02-07T10:43:10Z |
| Registrar | CSC Corporate Domains, Inc. |
| Registrar IANA ID | 299 |
| Registrar Abuse Contact Email | domainabuse@cscglobal.com |
| Registrar Abuse Contact Phone | 8887802723 |
| Domain Status | clientTransferProhibited https://icann.org/epp#clientTransferProhibited |
| Name Server | NS-1041.AWSDNS-02.ORG |
| Name Server | NS-1583.AWSDNS-05.CO.UK |
| Name Server | NS-396.AWSDNS-49.COM |
| Name Server | NS-701.AWSDNS-23.NET |
| DNSSEC | unsigned |
| URL of the ICANN Whois Inaccuracy Complaint Form | https://www.icann.org/wicf/ |
| >>> Last update of whois database | 2026-07-30T16:13:14Z <<< |
| For more information on Whois status codes, please visit https | //icann.org/epp |
| NOTICE | The expiration date displayed in this record is the date the |
| TERMS OF USE | You are not authorized to access or query our Whois |
| by the following terms of use | You agree that you may use this Data only |
| to | (1) allow, enable, or otherwise support the transmission of mass |